👉 Diabetes missiles, also known as GLP-1 receptor agonists or SGLT2 inhibitors, are a class of medications used in the management of type 2 diabetes. These drugs work by mimicking or enhancing the action of glucagon-like peptide-1 (GLP-1), a hormone that regulates blood sugar levels. GLP-1 agonists increase insulin secretion in response to meals, suppress glucagon release, slow gastric emptying, and promote satiety, thereby reducing blood glucose levels. SGLT2 inhibitors, on the other hand, block the reabsorption of glucose in the kidneys, leading to increased glucose excretion in urine. Both classes of drugs have additional benefits, such as weight loss and cardiovascular protection, making them valuable tools in diabetes management.
